Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Mar 2022 16:00

RNS Number : 9118D
ReNeuron Group plc
07 March 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF5G6K95

Issuer Name

RENEURON GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

10-Feb-2022

6. Date on which Issuer notified

16-Feb-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.734800

3.035000

3.769800

2151158

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF5G6K95

419300

0.734800

Sub Total 8.A

419300

0.734800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

1731858

3.035000

Sub Total 8.B1

1731858

3.035000%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Matthew Allen01727895011

12. Date of Completion

16-Feb-2022

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEASDXESPAEFA
Date   Source Headline
9th Oct 20069:50 amRNSTo Present Data in October
21st Sep 200611:49 amRNSRe: Warrant Holder Meeting
21st Sep 200611:45 amRNSAGM Statement
19th Sep 20063:39 pmRNSIssue of Equity
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:23 pmRNSDirector/PDMR Shareholding
4th Sep 20065:18 pmRNSDirector/PDMR Shareholding
30th Aug 200612:03 pmRNSHolding(s) in Company
30th Aug 200611:57 amRNSHolding(s) in Company
23rd Aug 20063:19 pmRNSAGM
23rd Aug 20067:01 amRNSRe: Clinical Investigator
29th Jun 20062:21 pmRNSHolding(s) in Company
29th Jun 20067:02 amRNSResearch Update
28th Jun 20067:01 amRNSRe Placing
28th Jun 20067:01 amRNSFinal Results
26th Jun 20063:27 pmRNSNotice of Results
5th Jun 20067:02 amRNSConference
11th May 20062:35 pmRNSHolding(s) in Company
26th Apr 20065:17 pmRNSDirector/PDMR Shareholding
26th Apr 20065:13 pmRNSDirector/PDMR Shareholding
26th Apr 20065:09 pmRNSDirector/PDMR Shareholding
26th Apr 20065:03 pmRNSDirector/PDMR Shareholding
26th Apr 20064:59 pmRNSDirector/PDMR Shareholding
18th Apr 20067:02 amRNSRe Agreement
18th Apr 20067:02 amRNSRe Agreement
10th Apr 20061:52 pmRNSHolding(s) in Company
5th Apr 20069:08 amRNSIntention to raise funds
4th Apr 20069:52 amRNSResearch Update
8th Mar 20067:32 amRNSResearch Update
7th Mar 20067:00 amRNSRe: BioSquare Conference
16th Feb 20067:01 amRNSResearch Update
7th Feb 20067:01 amRNSRe: Manufacturing Contract
6th Feb 20067:01 amRNSResearch Update
24th Jan 20067:00 amRNSRe US Patent Office
6th Dec 200510:03 amRNSRe Conference
2nd Dec 200511:19 amRNSRe: Government Support
30th Nov 20057:00 amRNSInterim Results
23rd Nov 20054:57 pmRNSNotice of Results
18th Nov 20057:00 amRNSResearch Update
25th Oct 20057:00 amRNSResearch Update
5th Oct 20059:59 amRNSHolding(s) in Company
22nd Sep 200510:31 amRNSResearch Update
20th Sep 20059:13 amRNSDirector/PDMR Shareholding
16th Sep 20051:08 pmRNSDirector/PDMR Shareholding
16th Sep 20051:06 pmRNSDirector/PDMR Shareholding
16th Sep 20051:05 pmRNSDirector/PDMR Shareholding
16th Sep 20051:03 pmRNSDirector/PDMR Shareholding
16th Sep 20051:01 pmRNSDirector/PDMR Shareholding
12th Aug 20057:00 amRNSAdmission to Trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.